< PreviousEXHIBITION GUIDE – ECCVID 202020 14:15 - 15:45 Virtual Industry Learning Advancing COVID-19 diagnostic innovation across the testing pathway: A scientific expert panel discussion with live Q&A Chair 14:15 Introduction Fernand Goldblat (Switzerland) 14:20 BD MAX and BD Veritor development Celine Roger-Dalbert (United States) 14:30 BD Veritorclinical performance study Steve Young (United States) 14:50 Clinical utility and value of diagnostic testing Charles K. Cooper (United States) 15:05 Emergency Department challenges during the COVID-19 pandemic Luis Garcia-Castrillo Riesgo (Spain) 15:20 Live Q&A Organised by Wednesday, 23 September 2020EXHIBITION GUIDE – ECCVID 202021 15:00 - 16:00 Virtual Industry Learning Testing patients suspected of COVID-19: Clinicians from New York and Rio de Janeiro share their perspectives 15:00 Welcome & Introductions Henri Bendelac (United States) COVID-19 testing strategies for disease surveillance and control Michael Joseph Mina (United States) Live Q&A with Dr. Mina Henri Bendelac (France) Evaluating Panbio™ COVID-19 Ag Rapid Test Device with Nasopharyngeal Swab Amilcar Tanuri (Brazil) Live Q&A with Dr. Tanuri Luis Gonzalez (United States) Organised by Wednesday, 23 September 2020EXHIBITION GUIDE – ECCVID 202022 13:00 - 14:00 Virtual Industry Learning The role of diagnostic solutions for COVID-19 patients: diagnosis, prognosis, complications and follow-up Chair Mark Miller During this talk, we will explain how diagnostics have been and continue to be pivotal in managing the unprecedented COVID-19 pandemic. We will cover the various roles of diagnostic tests in COVID-19: • Diagnosing suspected cases • Prognosis of COVID-19 patients • Diagnostics for co-infections, secondary infections, healthcare-associated infections (HAIs) and acute kidney injury (AKI) in COVID-19 patients • The role of diagnostics “post-COVID-19”: immunity, vaccine development Organised by Thursday, 24 September 2020EXHIBITION GUIDE – ECCVID 202023 14:00 - 14:40 Virtual Industry Learning ‘Twindemic’ Beyond the outbreak & more Industry Chair Carsten Tiemann (Germany) 14:00 The COVID-19 testing response in Wales, UK Catherine Moore (United Kingdom) Innovative multiplex assay for the upcoming flu season Eugene (Seong-Youl) Kim (South Korea) Organised by Thursday, 24 September 2020EXHIBITION GUIDE – ECCVID 202024 14:30 - 15:30 Virtual Industry Learning Managing scarcity: effective algorithms incorporating innovative technologies for administering COVID-19 diagnostics testing in hospitals and community Chair Juergen Becker (Germany) 14:30 Company Introduction 14:35 Developing a case for effective utilisation of antigen POC testing for COVID-19 in the emergency department and community Roland Diel (Germany) 15:00 An institutional approach to managing COVID-19 diagnostics with in-house real-time PCR based upon atypical testing demands Joeffrey Chahine (United States) 15:25 Live Q&A Organised by Thursday, 24 September 2020EXHIBITION GUIDE – ECCVID 202025 14:45 - 15:45 Virtual Industry Learning Current challenges & learning to advance Antibiotic Stewardship in the wake of Coronavirus 14:45 Introduction 14:50 Virtual round table discussion What are the implications of the pandemic on Antimicrobial Resistance (AMR)? What advantages do existing stewardship programmes bring in the context of a pandemic response? What immediate adaptations have you seen taking place in your workspace? On the assumption we are now entering the medium-term of the pandemic, what evolution has taken place in patient care? What do you think the longer-term requirements to manage coronavirus patients might look like? Do you believe the Coronavirus pandemic will lead to larger, more fundamental longer-term changes in Stewardship programs (reference to antibiotic surveillance) globally? 15:30 Live Q&A Organised by Friday, 25 September 2020EXHIBITION GUIDE – ECCVID 202027 Virtual Integrated Sessions (VIS) Wednesday, 23 September 2020 VIS 09:00 - 10:00 Targeting SARS-CoV-2: novel vaccines and antivirals for the prevention and treatment of COVID-19 10:15 - 11:15 Breakthrough of pandemic times: COVID-19 faces the next pandemic Afternoon Sessions 17:00 - 17:50 COVID-19 secondary infections: understanding the threat of opportunistic bacteria and fungi 18:30 - 19:30 Secondary bacterial and co-infections complicating COVID-19: a comparison and contrast to influenza EXHIBITION GUIDE – ECCVID 202028 Virtual Integrated Sessions (VIS) Thursday, 24 September 2020 VIS 17:15 - 18:15 Accelerating viral research workflows, vaccine and drug development 17:15 - 18:15 Invasive fungal infections and COVID-19: expect the unexpected? EXHIBITION GUIDE – ECCVID 202029 Virtual Integrated Sessions (VIS) Friday, 25 September 2020 VIS Afternoon Sessions 18:30 - 19:30 Bringing antiviral expertise to pandemic times Next >